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Ethnopharmacological relevance: Baccharis trimera (Less.) DC. (Asteraceae) is a species native to South
America used in Brazilian folk medicine to treat gastrointestinal and liver diseases, kidney disorders and
diabetes. Previous studies from this laboratory conﬁrmed the antacid and antiulcer activities of the plant
aqueous extract (AE) in rat and mouse models.
Aim of the study: To investigate the mechanisms involved in the antacid action of AE and isolated com-
pounds from Baccharis trimera.
Materials and methods: AEwas assayed in vivo in cold-restraint stress gastric ulcers and in pylorus-ligated
mice. Nine fractions (F2–F10) previously isolated from AE were assayed in vitro on acid secretion mea-
sured as [14C]-aminopyrine ([14C]-AP) accumulation in rabbit gastric glands, and on gastric microsomal
H+, K+-ATPase preparations. Chlorogenic acids (F2, F3, F6, F7), ﬂavonoids (F9), an ent-clerodane diterpene
(F8) and a dilactonic neo-clerodane diterpene (F10) have been identiﬁed in these fractions.
Results: Intraduodenal injection of AE (1.0 and 2.0 g/kg) in 4h pylorus-ligated mice decreased the volume
(20 and 50%) and total acidity (34 and 50%) of acid secretion compared to control values. Administered
orally at the same doses AE protected against gastric mucosal lesions induced in mice by restraint at 4 ◦C.
Exposure of isolated rabbit gastric glands to fractions F8 (10–100M) and F9 (10–300g/ml) decreased
the basal [14C]-AP uptake by 50 and 60% of control (Ratio =6.2±1.1), whereas the remaining fractions
were inactive. In the presence of the secretagogues F2 and F4 (30–300g/ml) decreased the [14C]-AP
uptake induced by histamine (His) with a 100-fold lower potency than that of ranitidine. F5 and F6
reduced the [14C]-AP uptake stimulated by carbachol (CCh), but they were 10 to 20-fold less potent
than atropine. F8 (diterpene 2) and F9 (ﬂavonoids) decreased both the His- and CCh-induced [14C]-AP
uptake, whereas F10 (diterpene 1) was inactive against the [14C]-AP uptake stimulated by secretagogues.
Diterpene 2 was the most active of all tested compounds being 7-fold less potent than ranitidine and
equipotent to atropine in reducing acid secretion in vitro. This compound also reduced the gastric H+, K+-
ATPase activity by 20%of control,while the remaining fractionswere inactive on the protonpump in vitro.
Conclusions: The results indicate that Baccharis trimera presents constituents that inhibit gastric acid
secretion by acting mainly on the cholinergic regulatory pathway. The plant extract also contains com-
pounds that exert moderate inhibition of the histaminergic regulatory pathway of acid secretion and the
gastric proton pump. Altogether these active constituents appear to provide effective inhibition of acid
secretion in vivo, which may explain the reputed antiulcer activity of the plant extract.
Abbreviations: [14C]-AP, [14C]-aminopyrine; CCh, carbachol; DMSO, dimethyl
ulfoxide; ECL, enterochromafﬁn-like cells; EDTA, ethylenediaminetetraacetic acid;
+, K+-ATPase, H+, K+-adenosine triphosphatase; His, histamine; HPLC, high perfor-
ance liquid chromatography; NMR, nuclear magnetic resonance; PBS, phosphate
uffered saline; TRIS, tris(hydroxymethyl)aminomethane.
∗ Corresponding author at: Escola Paulista de Medicina, Universidade Federal de
ão Paulo, Department of Pharmacology, Natural Products Section, 04044-020 Rua
rês deMaio 100, São Paulo, SP, Brazil. Tel.: +55 1155764447; fax: +551150813849.
E-mail address: csouccar@unifesp.br (C. Souccar).
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1. Introduction
A number of plant species are reputed in Brazilian folkmedicine
to possess antacid/antiulcer properties, one of the most popular of
which is Baccharis trimera (Less.) DC (Syn. Baccharis genistelloides
Persoon var. trimera (Less.) Baker; Baccharis triptera DC), family
Open access under the Elsevier OA license. Asteraceae (Magalhães, 2000). Commonly known as “carqueja”,
Baccharis trimera is one of the 120 species of the genus Baccha-
ris found in Brazil (Verdi et al., 2005), mainly in the Southern and
Eastern regions (Sousa et al., 1991). Used as infusion, decoctions or
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inctures of the aerial parts, the plant is also believed to be effec-
ive in liver diseases, diarrhea, fever, rheumatism, angina, renal
isorders and diabetes (Lorenzi and Matos, 2002).
Some biological activities of Baccharis trimera have been
hown experimentally. For example, antinociceptive and anti-
nﬂammatory activities of the plant aqueous extract and its
utanolic fraction have been described in rodent models (Gené
t al., 1996; Paul et al., 2009). Antihepatotoxic activity of the
lant ethyl acetate extract has been reported in a mouse model,
nd related to the presence of ﬂavonoids (Soicke and Leng-
eschlow, 1987). A possible antidiabetic activity was suggested
y the decrease in glycemia in mice with streptozotocin-induced
iabetes after 7 days treatment with an aqueous fraction of the
lant extract (Oliveira et al., 2005). Antioxidant (Simões-Pires et al.,
005), antimutagenic (Nakasugi and Komai, 1998), antimicrobial
Betoni et al., 2006), anti-hemorrhagic and anti-proteolytic activi-
ies against Bothrops snake venoms (Januário et al., 2004) have also
een reported for extracts and isolated compounds from Baccha-
is trimera. Moreover, signs of liver and renal toxicity have been
etected after 20 days of treatment in pregnant rats with the
ydroethanolic extract of Baccharis trimera (Grance et al., 2008).
he main constituents identiﬁed in this species are diterpenoid
ompounds (clerodane and labdane types), triterpenes, ﬂavonoids,
aponins, tannins, phenolic compounds and essential oils (Sousa et
l., 1991; Verdi et al., 2005).
Previous studies from this laboratory have shown that pretreat-
ent of rats and mice with the aqueous extract of aerial parts of
accharis trimera (AE, 5%) reduced gastric ulcers induced by 50%
thanol or cold-restraint stress, but were ineffective against those
roduced by nonsteroidal anti-inﬂammatory agents (Gamberini
t al., 1991). Administered intraduodenally in pylorus-ligated rats,
he AE reduced the basal gastric acid secretion as well as that stim-
lated by either bethanechol or pentagastrin, but not that induced
y histamine (Gamberini et al., 1991; Lapa et al., 1992). This indi-
ated the presence of active constituents in the AE that inhibit the
holinergic regulatory pathway of acid secretion.
Chemical studies have shown the presence in Baccharis trimera
xtract of a neo-clerodane diterpene endowed with a spasmolytic
ction on the vascular smooth musculature (Torres et al., 2000).
hlorogenic acids, ﬂavonoids, and an ent-clerodane diterpene have
lso been identiﬁed in the plant AE (Tanae et al., 2008). This work
imed to examine the mechanisms involved in the antisecretory
ction of the previously isolated compounds from Baccharis trimera
E (Torres et al., 2000; Tanae et al., 2008) on in vitro rabbit gastric
lands and gastric microsomal H+, K+-ATPase preparations.
. Materials and methods
.1. Plant material and extraction
Baccharis trimera was cultivated at the Pluridisciplinary Center
f Chemical, Biological and Agronomic Studies of the University of
ampinas in the state of SãoPaulo (Magalhães, 2000). Theplantwas
ollected inDecember 2000 and a voucher specimenwas deposited
n the herbarium of this Center as CPQBA 1286. The aerial parts
f the dried plant were extracted (5%, w/v) with hot water (72 ◦C,
0min), then the aqueous extract (AE) was concentrated under
acuum and freeze-dried (yield 12%, w/w).
.2. Puriﬁcation of AEPuriﬁcation of AE and chemical identiﬁcation of the main active
onstituentswere reported previously (Tanae et al., 2008). In short,
E was fractionated using a preparative HPLC system (Shimadzu,
apan) and a UV–vis detector operating at 210nm, and a Shim-armacology 136 (2011) 368–373 369
packpreparativeC18columnelutedwithwater/acetonitrile 3–70%.
Puriﬁcation of AE yielded 10 fractions (F1–F10) that were ana-
lyzed on an HPLC system (Shimadzu-Japan), monitored by an
SPD-M10AVP diode array detector. 1H NMR and 13C NMR spectral
analysis was used for chemical identiﬁcation of the main isolated
constituents.
2.3. Animals
In vivo assays of acid secretion were done using F1 mice
(25–30g) (Souccar et al., 2008) thatwere bred in theAnimal Facility
at Instituto Nacional de Farmacologia e BiologiaMolecular (INFAR),
Escola Paulista de Medicina/Universidade Federal de São Paulo
(EPM/UNIFESP). Animals were housed under controlled temper-
ature (22±2 ◦C) on a 12/12h light–dark cycle, with free access to
food and water. They were deprived of solid food 15–18h before
the experiments. When necessary they were anesthetized with a
mixture of xylazine (10mg/kg) andketamine (100mg/kg), i.p;male
white rabbits (2.5–4.0 kg) were obtained from a trusted local sup-
plier. All experimentswere carriedout in accordancewith theGuide
for the Care and Use of Laboratory Animals of the USA National Insti-
tutesofHealth (Bethesda,Maryland), andafter approval by the local
Animal Investigation Ethics Committee (License N◦ 761/07).
2.4. Drugs and chemicals
Drugs used were: ATP disodium salt, atropine sulfate, car-
bamoylcholine chloride, histamine dihydrochloride, collagenase
type IA, bovine serum albumin (BSA Fraction V), dimethyl sul-
foxide (DMSO), sodium thiocyanate (Sigma–Aldrich, St. Louis,
MO, U.S.A.), omeprazole (Biosintética, Brazil), ranitidine (Antak®,
Glaxo SmithKline, Brazil), scintillation cocktail Optiphase HISAFE
II (Packard Instruments Co., CT, U.S.A.), [dimethylamine-14C]-
aminopyrine (speciﬁc activity 109mCi/mmol, GE Healthcare Life
Sciences). All other chemicals were of analytical grade. For test-
ing, the fractions were prepared in phosphate buffered saline (PBS)
except fractions F8, F9 andF10whichweredissolved inDMSO (ﬁnal
concentration=0.05%). Appropriate concentrations of the vehicle
prepared with the incubation medium were used as control.
2.5. Experimentally induced gastric ulceration
Fasting mice were given by gavage tap water (0.1ml/10g body
wt, p.o.), the plant extract (AE, 1.0 and 2.0 g/kg) or the H2 receptor
antagonist ranitidine (0.05g/kg, positive control). After 1h gastric
lesions were induced by stress (restraint for 2h at 4 ◦C) (Senay and
Levine, 1967), and at the end of this procedure animalswere eutha-
nized under anesthesia. The stomachswere dissected out, slit along
the greater curvature, themucosal sidewas gently cleaned and this
was then examined under magniﬁcation (10×) by two observers
unaware of the treatments. The index of mucosal damage (IMD)
of each stomach was the sum of grades determined according to
the following scale: loss of mucosal folds, mucosal discoloration,
edema or hemorrhage (grade 1 each); less than 10 petechiae (grade
2), more than 10 petechiae (grade 3); ulcers/cm2 less than 1mm
(=number of ulcers×2); ulcers greater than 1mm/cm2 (=number
of ulcers×3); perforated ulcers (=number of ulcers×4).
2.6. Pylorus ligature
Fasting mice were anesthetized and a pylorus ligature was per-
formed as previously described (Schultz et al., 2007). The AE (1.0
and 2.0 g/kg) or the positive control ranitidine (0.05g/kg) was then
injected into the duodenal lumen (i.d.) and the abdominal wall was
sutured. Control animals received corresponding volumes of saline.
After 4h the animalswere euthanized under anesthesia, the gastric
3 hnopharmacology 136 (2011) 368–373
s
m
N
2
d
d
w
t
a
t
t
t
1
i
2
o
S
l
d
t
c
s
w
a
0
a
r
N
t
1
m
r
2
g
c
A
u
m
m
o
(
f
1
1
p
(
z
c
2
c
e
T
(
c
Table 1
Effects of the aqueous extract (AE) of Baccharis trimera administered by gavage on
gastric mucosal lesions induced by cold-restraint stress in mice.
Treatment Cold-restraint stress
IMD Number of ulcers cm−2
Control (7) 26.8 ± 2.6 16.2 ± 2.1
AE 1.0 g/kg (6) 19.8 ± 3.2 8.8 ± 2.9
AE 2.0 g/kg (6) 15.7 ± 2.6* 7.7 ± 2.9*
Ranitidine 0.05g/kg (6) 14.3 ± 1.7** 5.2 ± 2.4**
IMD, index of mucosal damage. Data are means± SD of the number of animals in
parenthesis.
* p<0.05, different from the corresponding control group (Kruskall–Wallis test70 T.M.A. Biondo et al. / Journal of Et
ecretion was collected and its ﬁnal volume and pH were deter-
ined. Total acidity of the gastric juice was titrated with 0.01N
aOH, using 2% phenolphthalein as indicator.
.7. Gastric glands preparation
Gastric glands were prepared from rabbit gastric mucosa as
escribed by Berglindh and Öbrink (1976). Brieﬂy, the rabbit was
eeply anesthetized with pentobarbital sodium, i.v., the stomach
as perfused under pressure with phosphate buffered saline and
hen dissected out. The fundic mucosa was scraped off, minced
nd incubated in a collagenase (Sigma type IA, 0.2mg/ml) solu-
ion for 30min at 37 ◦C. The gastric glands suspension was ﬁltered
hrough a nylon mesh and washed several times with the incuba-
ion medium (in mM: NaCl 132.4, KCl 5.4, Na2HPO4 5.0, NaH2PO4
.0, MgSO4 1.2, CaCl2 1.0, pH 7.4) by resuspension and gravity sed-
mentation.
.8. [14C]-aminopyrine ([14C]-AP) accumulation
Accumulation of the weak base [14C]-AP was used as a measure
f acid secretion by the gastric glands (Berglindh andÖbrink, 1976).
amples of the glands suspension (0.5ml) were incubated in trip-
icates with either the vehicle, the test fractions or the reference
rugs ranitidine (10m) and atropine (10M), the agonists his-
amine (1M) or carbachol (10M), and 0.05Ci [14C]-AP (ﬁnal
oncentration), at 37 ◦C in a shaker bath. After 30min incubation,
amples were centrifuged (15,000× g, 30 s) and the supernatants
ere separated. The gland pellets were dried at 90 ◦C for 2h,
nd after determination of their weights they were digested with
.2ml of 1M NaOH at 90 ◦C, for 1h. Samples of the supernatants
nd digested pellets were transferred to scintillation vials and the
adioactivitywas counted in a beta-counter (Packard Instruments).
onspeciﬁc trapping of [14C]-AP was determined in samples con-
aining 10mM NaSCN, an inhibitor of acid secretion (Hersey et al.,
981). Accumulation of [14C]-AP in the gastric glands was deter-
ined as the ratio (R) of the trapped glandular radioactivity to the
adioactivity of the incubation medium (Berglindh et al., 1976).
.9. Preparation and enzymatic assay of gastric H+, K+-ATPase
Microsomal gastric H+, K+-ATPase was prepared from rabbit
astric mucosal homogenates by Ficoll/sucrose density gradient
entrifugation as described by Rabon et al. (1988). The H+, K+-
TPase enriched fraction collected at the 12% Ficoll interface was
sed in all assays and protein content was determined by the
ethod of Bradford (1976). The enzymatic activity was deter-
ined in samples containing 40mMTris HCl buffer, pH 7.4, 0.1mM
uabain, 20mM KCl, 2mM MgCl2 and 10g membrane protein
0.5ml ﬁnal volume), in the absence and presence of the tested
ractions. The reactionwas started by addition of 1.0mMATP. After
0min incubation at 37 ◦C, the reaction was stopped by addition of
ml ice-cold trichloroacetic acid 10% and the released inorganic
hosphate was estimated by the method of Fiske and Subbarow
1925). Samples incubatedwith theprotonpumpinhibitoromepra-
ole in acidiﬁed assay buffer (pH=5.0) were used for positive
ontrol.
.10. Statistics
Data were expressed as means± SD. Half-maximal inhibitory
oncentrations (IC50) were determined from inhibition curves and
xpressed as geometric means and 95% conﬁdence intervals (CI).
he results were compared using one-way analysis of variance
ANOVA) followed by the Dunnett test. Non parametric data were
ompared using the Kruskall–Wallis test and Dunn’s post hoc test.and Dunn’s post hoc test).
** p<0.001, different from the corresponding control group (Kruskall–Wallis test
and Dunn’s post hoc test).
All data analysis was done using the software Graphpad Prism
version 5.00 for Windows (GraphPad Software, San Diego, CA). Dif-
ferences among data were considered signiﬁcant at p<0.05.
3. Results and discussion
Before evaluationof themechanisms involved in theantacid and
antiulcer activities of Baccharis trimera and isolated compounds,
both effects of the plant AE were ﬁrst conﬁrmed in mice in vivo
at doses equivalent to those used in popular medicine (Lorenzi
and Matos, 2002). Pretreatment of mice with 1.0 and 2.0 g/kg of
AE, p.o., protected against gastric ulcers induced by cold-restraint
stress reducing the IMD by 26 and 41%, and the number of ulcers by
46 and 52% of the respective control values (Table 1). In compari-
son, pretreatment of mice with ranitidine (0.05g/kg, p.o.) reduced
the IMD by 47%, and the number of ulcers by 68% of control values
(Table 1). In pylorus-ligatedmice intraduodenal injection of 1.0 and
2.0 g/kg of AE reduced the volume by 20 and 50%, and total acidity
of acid secretion by 34 and 50% of control values (1.2±0.1ml and
2.2±0.2mEq [H+]/l/4h, respectively) after 4h. The pH of the col-
lected secretion was not signiﬁcantly altered (control = 3.2±0.1)
with either dose (Fig. 1). These results indicate that the antiulcer
activity of Baccharis trimera AE is related to inhibition of acid secre-
tion, in agreement with previous studies (Gamberini et al., 1991;
Lapa et al., 1992).
To determine the mechanisms involved in the antacid activity,
nine fractions (F2–F10) obtained from the same AE (Tanae et al.,
2008) were assayed on the accumulation of [14C]-AP in isolated
gastric glands, a method that indirectly measures acid secretion
in vitro (Berglindh and Öbrink, 1976).
In isolated rabbit gastric glands the basal acid secretion
expressed as the ratio of intraglandular [14C]-AP to that present
in the incubation medium was 6.22±1.10 (n=19). Incubation with
histamine (His; 1, 10 and 100M) increased the [14C]-AP uptake
in a concentration-related manner by 119±7%, 193±11% and
202±14% of basal values, respectively. In the presence of carba-
chol (CCh; 1, 10 and 100M) [14C]-AP accumulation in the gastric
glands did not change at 1M, but it was increased by 168±15%
and 268±24% of the basal value at 10 and 100M, respectively.
Incubation with F2–F7 (10–300g/ml) did not affect the basal
[14C]-AP accumulation in gastric glands preparations. Previous
chemical studies have identiﬁed the presence of chlorogenic acids
in some fractions such as 5′-O-caffeoylquinic acid (F2), 4-O-[E]-
caffeoyl-1-methyl-quinic acid (F3), 1′-5′-O-dicaffeoylquinic acid
(F6), and 1,3-di-[E]-caffeoylquinic acid (F7) (Tanae et al., 2008).
Caffeoyl quinic acid derivatives are characteristic of Asteraceae
(Clifford, 2000), and have been reported in extracts of Baccharis
trimera, Baccharis crispa and Baccharis usteri (Simões-Pires et al.,
2005),Baccharis dracunculifolia (Nagatani et al., 2002) andBaccharis
gaudichaudiana (Akaike et al., 2003).
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Fig. 1. Effect of the aqueous extract of Baccharis trimera (AE, 1.0 and 2.0 g/kg)
injected intraduodenally (i.d.) on the volume (A) and total acidity (B) of gastric
secretion collected from mice 4h after pylorus ligation. Control animals were given
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Fig. 2. Effects of fractions F2, F4 and F9 isolated from Baccharis trimera extract
on [14C]-aminopyrine ([14C]-AP) accumulation in rabbit gastric glands stimulated
14
less potent than atropine (Table 2). These results indicate that the
antacid action of Baccharis trimera active constituents is mediated
mainly by inhibition of the cholinergic regulatory pathway of acid
Fig. 3. Effects of fractions F5, F6 and F9 isolated from Baccharis trimera extractaline (C, 0.1ml/10g body wt, i.d.). The columns and vertical bars are means± SE of
animals. ** different from control (p<0.01).
Fractions F8 (10–100M), identiﬁed as an ent-clerodane diter-
ene (diterpene 2) (Tanae et al., 2008), and F9 (10–300g/ml),
ainly consisting of ﬂavonoids (Torres et al., 2000; Tanae et al.,
008) decreased the basal [14C]-AP uptake at the highest concen-
rations (by 52% and 58% of control, respectively). Fraction F10
10–100M), which contained a neo-clerodane diterpene (diter-
ene 1) with a smooth muscle relaxant activity (Torres et al., 2000)
id not inﬂuence the basal [14C]-AP uptake in the gastric glands
reparation.
Gastric acid secretion is stimulated by, (a) histamine release
rom enterochromafﬁn-like cells (ECL) in the oxyntic glands, (b)
astrin, released from G cells in the pyloric gastric glands, and
c) acetylcholine, released from postganglionic enteric neurons.
istamine-induced acid secretion is mediated by H2 receptors
n parietal cells that are coupled to the adenylate cyclase signal
ransduction pathway. Cholinergic and gastrin direct stimula-
ion of acid secretion by parietal cells is mediated by M3 and
CK2 receptors, respectively, and involves an increase in the
ytosolic calcium concentration brought about via the inosi-
ol 1,4,5-triphosphate (IP3) pathway. Acetylcholine and gastrin
lso stimulate acid secretion indirectly by reducing the restraint
xerted by somatostatin on parietal cells and ECL, and by releas-
ng histamine from ECL, respectively. Activation of the gastric H+,
+-ATPase (proton pump) is the common ﬁnal step of acid secre-by histamine (His, 10M). [ C]-AP ratio (R) is expressed as percent of maximal
response to the secretagogue (R=31.9±4.5, n=5). Symbols and vertical bars are
means± SD of 3 assays each in triplicate. *different from control (p<0.05).
tion in both regulatory pathways (Schubert, 2009; Yao and Forte,
2003).
Tested in the presence of the secretagogues, F2 and F4
(10–300g/ml) decreased the His-induced [14C]-AP-uptake by 55
and 40% of control, respectively, at the highest concentration
(Fig. 2). By contrast, F3, F5, F6 and F7 (10–300g/ml) did not sig-
niﬁcantly change the His-induced [14C]-AP-uptake. This indicated
the presence of constituents in Baccharis trimera AE that inhibited
the histaminergic regulatory pathway of acid secretion and may
contribute to the plant’s anti-ulcer activity.
In the samerangeof concentrations, F5andF6 reduced the [14C]-
AP accumulation induced by CCh (10M) by 40–45% of control
(Fig. 3), whereas F2, F3, F4 and F7 were inactive. These results indi-
cated thepresence in theplantAEof constituents that also inhibited
the cholinergic regulatory pathway of acid secretion. Based on the
determined IC50 values, when compared to the reference drugs
the fractions that reduced the His-induced [14C]-AP uptake were
80 to 120-fold less potent than ranitidine, whereas those active
against the CCh-induced [14C]-AP accumulation were 10 to 20-foldon [14C]-aminopyrine ([14C]-AP) accumulation in rabbit gastric glands stimulated
by carbachol (CCh, 10M). [14C]-AP ratio (R) is expressed as percent of maximal
response to the secretagogue (R=15.2±3.2, n=5). Symbols and vertical bars are
means± SD of 3 assays each in triplicate. *different from control (p<0.05).
372 T.M.A. Biondo et al. / Journal of Ethnoph
Table 2
Mean effective inhibitory concentration (IC50) values of the active fractions iso-
lated from the aqueous extract of Baccharis trimera on [14C]-aminopyrine ([14C]-AP)
uptake stimulated by histamine and carbachol in rabbit gastric glands preparations.
Compound IC50
Histamine-induced
[14C]-AP uptake
Carbachol-induced
[14C]-AP uptake
F2 (5′-O-caffeoylquinic acid;
g/ml)
407a (246–674) –
F4 (NI; g/ml) 274 (141–535) –
F5 (NI; g/ml) − 343 (136–866)
F6 (1′-5′-O-dicaffeoylquinic
acid; g/ml)
− 182 (100–330)
F9 (ﬂavonoids; g/ml) 206 (100–421) 280 (157–498)
F8 (ent-clerodane diterpene;
M)
75 (44–128) 44 (30–65)
Ranitidine (M) 11 (7–18) −
Atropine (M) − 54 (26–115)
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(I, not identiﬁed.
a Results are geometricmeans and 95% conﬁdence intervals in parenthesis, of 3–6
eterminations in triplicate.
ecretion, a ﬁnding consistent with the reported inhibition of acid
ecretion in vivo stimulatedbybethanechol or pentagastrin, but not
y histamine in rats pretreatedwith the plant AE (Lapa et al., 1992).
Both the His- and CCh-induced [14C]-AP uptake were signif-
cantly decreased by the ﬂavonoids fraction (F9, 10–300g/ml)
Figs. 2 and 3) and diterpene 2 (F8, 10–100M) (Fig. 4). Diterpene
was the most active of all isolated compounds being 7-fold less
otent than ranitidine and equipotent to atropine in reducing the
14C]-APuptake inducedby the secretagogues (Table 2). In contrast,
iterpene 1 (F10, 10–100M) was ineffective against the [14C]-AP
ptake stimulated by the secretagogues. Inhibition of the [14C]-
P uptake induced by cholinergic and histaminergic stimulation
n the presence of the ﬂavonoids fraction and diterpene 2 indicate
possible inhibition of the H+, K+-ATPase, the ﬁnal common step of
cid secretion. Flavonoids (Murakami et al., 1999) and some diter-
enoids identiﬁed in plants endowed with antacid and antiulcer
ctivities such as scopadulciol and scopadulcic B isolated from Sco-
aria dulcis (Asanoet al., 1990;Hayashi et al., 1991), andplectrinone
isolated from Plecthranthus barbatus (Schultz et al., 2007) were
ig. 4. Concentration–response effects of diterpene 2 (F8) isolated from Baccha-
is trimera extract on [14C]-aminopyrine ([14C]-AP) accumulation in rabbit gastric
lands stimulated by histamine (His, 10M, ©), or carbachol (CCh, 10M,). [14C]-
P ratio is expressed as percent ofmaximal response to the respective secretagogue.
ontrol [14C]-AP ratio was 35.1±5.1 for His, and 19.1±3.9 for CCh (n=5). Symbols
nd vertical bars are means± SD of 3 assays in triplicate. *different from control
**p<0.01; ***p<0.001). Insert: chemical structure of diterpene 2.armacology 136 (2011) 368–373
shown to inhibit the gastric H+, K+-ATPase in vitro. The gastric pro-
ton pump, H+, K+-ATPase is a membrane-bound enzyme that upon
stimulation translocates to theapical cellmembraneandexchanges
H+ for K+, at the expense of ATP hydrolysis (Sachs et al., 1976).
In control preparations of rabbit gastric membrane vesicles, the
H+, K+-ATPase activity determined in the presence of 1mM ATP
was29.0±1.0molPi/mgprotein/h (n=8). Incubationofditerpene
2 (1M–1mM) decreased the enzyme activity by 20% of con-
trol at the highest concentration, whereas the ﬂavonoids fraction
(10–1000g/ml)was inactive. Thus, inhibitionof thegastric proton
pump appears unlikely to account alone for the antacid activity of
diterpene 2 and the ﬂavonoids fraction, suggesting that these con-
stituents exert their actions at intracellular sites upstream of the
proton pump. The target sites of these actions and the mechanisms
involved remain to be determined.
When tested at the same concentrations, none of the remaining
fractions affected signiﬁcantly the H+,K+-ATPase activity in vitro,
except F7 which decreased the enzyme activity by 20–30% at all
concentrations, indicating a non-speciﬁc action. In comparison, the
proton pump inhibitor omeprazol (10nM–1mM) inhibited the H+,
K+-ATPase activity with an IC50 =10M.
Gastric ulcers result from a predominance of aggressive fac-
tors (acid secretion, Helicobacter pylori, stress, use of nonsteroidal
antiinﬂammatory agents and ethanol) over protectivemechanisms
(mucus-bicarbonate, prostaglandin release, mucosal microcircula-
tion) (Ham and Kaunitz, 2007). Gastric mucosal lesions induced
by ethanol, stress or ischemia/reperfusion are accompanied by
the decrease of gastric blood ﬂow, increase of proinﬂammatory
cytokine mediators, generation of reactive oxygen species, and the
impairment of superoxide dismutase and protective antioxidative
mechanisms (Kwiecien et al., 2003). Phenolic compounds such as
plant-derived ﬂavonoids and chlorogenic acid isomers have been
reported to present gastroprotective effects unrelated to inhibition
of acid secretion and exhibit healing of gastric ulcers by increasing
thegastricmucosal bloodﬂowthrougha local releaseof nitric oxide
(NO), and by the release of calcitonin gene related peptide (CGRP)
from sensory afferent nerves (Zayachkivska et al., 2005). Phenolic
compounds also present free radical scavenging effects in vitro and
are believed to exert antioxidant actions in vivo protecting against
lipid peroxidation (Hamauzu et al., 2006; Izuta et al., 2009). How-
ever, the latter possibility has been questioned because phenolics
are hardly absorbed in the gut and are unlikely to reach the nec-
essary concentrations in target tissues to inﬂuence oxidative stress
(Crozier et al., 2009). Recent evidence indicates that metabolites of
phenolics may affect different intracellular signaling mechanisms
that are crucial for cellular functions which may be related to some
of the reputed beneﬁcial effects of natural products (Crozier et al.,
2009). Whether this also applies to the active compounds of Bac-
charis trimera remains to be examined.
4. Conclusions
The data reported here indicate that the AE of Baccharis trimera
presents active constituents that inhibit acid secretion by acting
predominantly on the cholinergic regulatory pathway. The plant
extract also contains constituents that exert moderate inhibition
of the histaminergic regulatory pathway of acid secretion, as well
as of the gastric H+, K+-ATPase. Altogether these active compounds
appear to provide effective inhibition of acid secretion in vivo,
which may explain the reputed antiulcer activity of the plant
extract. Nonetheless, the presented data do not exclude possible
additional gastroprotective effects related to a local increase of gas-
tric microcirculation induced by the plant phenolic constituents,
and/or actions of phenolic metabolites on intracellular signaling
pathways.
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